Lung cancer
DULCE
A parallel-group, 2-arm, Phase 2, multisite, stratified, double-blind, randomised, study to investigate the safety and effectiveness of doxycycline or placebo in conjunction with standard of care in adults with metastatic adenocarcinoma of the lung undergoing targeted anti-cancer therapy.
Trial overview
Clinical Area
Medical Oncology
Disease
Lung
Disease site
Lung & Bronchus
Study Phase
II
Trial Identifiers
Registration number: ACTRN12625000697482
Principal Investigator(s)
··
··